From:
Craig Abud [craig@nichemedical.ccsend.com] on behalf of Craig Abud
[craig@nichemedical.com.au]
Sent:
Tuesday, 17 November 2009 8:01 PM
To:
Craig Abud
Subject:
Niche News - November 2009
|
Having trouble viewing
this email? Click here |
|
You are receiving this
email from Niche Medical because you purchased a product/service, entered one
of our competitions at a medical conference or subscribed on our website. To
ensure that you continue to receive emails from us, add craig@nichemedical.com.au to your
address book today. If you haven't done so already, click to confirm your interest in receiving email campaigns from
us. You may unsubscribe if you no longer wish to receive our emails. |
|
|
|
|
Niche News |
|
|
||||||||||||||||||||||||||||||
|
Welcome to Niche Medical's Customer Newsletter. Niche Medical is proud to be a wholly owned Australian Company
and 2009 represents our tenth anniversary in the medical industry. We wish you and your families a very happy festive season and we
look forward to working with you in 2010. This newsletter is designed to inform our customers of the latest
information on our products and services. We highly value your input and feedback and encourage you to
send all feedback and comments to Craig Abud by simply replying to this
email. If for any reason you do not wish to receive this newsletter in
the future, simply click on the SafeUnsubscribe button at the bottom of this
newsletter. Please feel free to pass this newsletter onto those who may find
it valuable. There is a forward email icon located at the bottom of this
newsletter. Craig Abud, Niche Medical
In April this year the Victorian Ambulance Service adopted the
use of the LiteAire Disposable Spacer with MDI in all of their emergency
response vehicles. The following is an excerpt from the newsletter ''Lung Health
Matters'' which is a publication of the Lung Health Promotion Centre at the
Alfred Hospital in Melbourne and has been reproduced here with the kind
permission of Adrienne James. ''In 2007, Adrienne James and Associate Professor Frank Thien
raised concerns with the Victorian Ambulance Service regarding the use of
nebulisers with all asthma patients and the problems of COPD patients being
given too much oxygen.'' ''We have collaborated with the service since this time on
developing new guidelines. We are very pleased to let you know that this has
had a positive result and the Ambulance Service is changing their guidelines
for asthma and COPD management'' ''The asthma guidelines will now include MDI and spacer as a
first response for patients with mild to moderate asthma''. ''The guidelines for COPD have now been separated from the
asthma guidelines which means oxygen will be given at low flows to patients
with COPD exacerbations''. ''We are thrilled that we have been able to positively support
the Ambulance Service in making these changes so that there will be
consistency in the care and education of people with asthma and COPD''. "The new guidelines were introduced in April this
year". ENDS. The LiteAire Disposable Cardboard Spacer offers proven clinical
efficacy and convenience with minimal storage requirements and an
environmentally friendly alternative to large rigid plastic spacers. In a recent study published in the Journal of Emergency Medicine
it has been shown that the LiteAire Disposable Spacer is clinically
equivalent to nebuliser therapy in the treatment of acute asthma in the
Emergency Department setting. This is an important finding for the LiteAire Spacer given that
nebuliser therapy remains the mainstay for the treatment of acute asthma in
Australian Adult Emergency Departments. N.B. We are also pleased to report that the South Australian
Ambulance Service, Tasmanian Ambulance Service and St Johns Ambulance in
Queensland have also adopted the use of the LiteAire Spacer in their emergency
response vehicles.
In August this year we conducted a series of successful meetings
to launch the EasyOne Pro DLCO System to Respiratory Scientists. These meetings featured presentations from Associate Professor
Robert Jensen, Pulmonary Division, LDS Hospital, Salt Lake City, Utah and Mr
Bill Smith, Principal Scientist, Pulmonary Function Laboratory, Fremantle
Hospital, Perth WA. Thank you to our speakers Bob Jensen and Bill Smith and
facilitators Associate Professor David Johns, Associate Professor Alan
Crockett and Mr Paul Guy. A big thank you to all the Respiratory Scientists
who attended these meetings. The EasyOne Pro is a highly portable state of the art lung
function analyser which makes it possible to take the DLCO measurement out of
the Pulmonary Function Laboratory and to the patient. The EasyOne Pro is suitable for use in Pulmonary Function
Laboratories in both public and private settings, respiratory outreach
clinics, regional hospitals and to test hospital in-patients who cannot be
easily transported to the pulmonary function laboratory. Some of the features of the EasyOne Pro DLCO System are:
* ''Alveolar volume (VA) measured during the single- breath
diffusing capacity for carbon monoxide (DLCO) can be used as a substitute
measure for the multiple-breath total lung capacity (TLC) in subjects with
and without airways obstruction''. Reference: Correction of Single-Breath Helium Lung Volumes in
Patients With Airflow Obstruction, Punjabi et al, CHEST 114/3 SEPTEMBER,
1998. For a demonstration of the EasyOne Pro DLCO System simply reply
to this email or contact our office on 1300 136 855. N.B. We recorded one of the EasyOne Pro launch meetings for
those who were unable to attend and I am pleased to advise that the DVD
recording of the meeting is now available free of charge on request.
Vapotherm, the leading innovator and the inventor of high flow
oxygen therapy takes the science of heating and humidifying breathing gas to
a dramatic new level with the creation of Precision Flow. INNOVATIVE, SUPERIOR TECHNOLOGY Precision Flow is a high flow heat and humidification device for
the non-invasive delivery of inspired gas flows from 1-40 litres per minute. This unique technology delivers a perfect synchronisation of
flow, temperature, humidity and oxygen percentage without discomfort via
nasal cannula. Precision Flow moves beyond conventional humidification, giving
the clinician the ability to manage the key factors in gas conditioning to
achieve desired outcomes. MAXIMUM SAFETY, MINIMAL INVASIVENESS Precision Flow helps clinicians reach their goal to deliver the
maximum respiratory assistance safely and comfortably. No other High Flow
device incorporates these safety features:
DESIGNED FOR EASE OF USE Working with the respiratory community, Precision Flow was
designed with Nurses and Physiotherapists in mind, providing easy set-up,
operation and maintenance including:
Precision Flow allows for the delivery of a broad range of flows
at up to 100% relative humidity, providing effective, well-tolerated
treatment for a variety of conditions via nasal cannula. CLINICAL INDICATIONS FOR HIGH FLOW NASAL CANNULA Patients ranging in ages from preterm newborns to adults are now
receiving flow rates ranging from 2 to 40 L/min via nasal cannula to support
breathing through a variety of conditions. (1). In newborns, high flow devices are being used in the preterm
population with respiratory distress syndrome as well as a mode for oxygen
delivery in full term newborns with hypoxic respiratory failure. (1). In the paediatric age range, high flow devices are finding use
in typical situations that might have otherwise required intubation or CPAP.
Disease processes from infectious causes of pulmonary dysfunction such as
viral bronchiolitis or bacterial pneumonia to reactive airway disease are now
being treated with high flow nasal cannula devices. (1). In adults, these devices are used in a variety of clinical
settings where increased flow rates are believed to benefit the patient in
the context of their respiratory disease. These adult disease processes range
from pulmonary oedema to chronic obstructive pulmonary disease (COPD) to
acute respiratory distress syndrome (ARDS) post-extubation. (1). There are now over 60 clinical studies published on Vapotherm. Reference (1). Research in high flow therapy: Mechanisms of
action, Dysart et al, Respiratory Medicine 2009. For a product demonstration or a free clinical evaluation of Vapotherm
Precision Flow in your healthcare facility simply reply to this email or
contact our office on 1300 136 855.
We have recently introduced a Portable Ultrasonic Nebuliser
designed specifically for the delivery of Hypertonic Saline in the treatment
of Bronchiectasis and Cystic Fibrosis. The rationale behind our introduction of this product is simple.
A jet nebuliser will deliver hypertonic saline at around 0.3mls per minute
whereas the portable ultrasonic nebuliser is more than three times faster at
a delivery rate of 1ml per minute. The portable ultrasonic nebuliser will deliver 4mls of
hypertonic saline in 4 minutes which can significantly improve patient
compliance. The product features are:
For a product demonstration or further information simply reply
to this email or contact our office on 1300 136 855.
|
||||||||||||||||||||||||||||||
|
email: craig@nichemedical.com.au phone: 1300 136 855 |
||||||||||||||||||||||||||||||
|
|
|
|
||||||
